Fate Therapeutics, Inc. · NASDAQ:FATE
BlackRock, Inc.'s stake in Fate Therapeutics, Inc. fell to 1.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 8, 2026
BlackRock, Inc.'s stake in Fate Therapeutics, Inc. fell to 1.90%, 2,194,284 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).
- Stake
- 1.90%
- Shares
- 2,194,284
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 1.90% | 2,194,284 |